1975
DOI: 10.1038/bjc.1975.81
|View full text |Cite
|
Sign up to set email alerts
|

High affinity oestradiol receptors and the activity of glucose-6-phosphate dehydrogenase and lactose synthetase in mammary carcinomata of postmenopausal women

Abstract: Summary.-The determination of hormone inducible proteins in endocrine tumours may yield information about the presence of hormone dependent tumour cells. We have estimated the high affinity oestradiol binding capacity in primary mammary carcinomata of 57 postmenopausal patients. Glucose-6-phosphate dehydrogenase and lactose synthetase are known from animal experiments to be hormone inducible. Therefore, in biopsies of sufficient size the activity of glucose-6-phosphate dehydrogenase (47 patients) and lactose s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1977
1977
1990
1990

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…There is well-documented evidence that oestradiol-17, induces glucose-6-phosphate dehydrogenase (GPDH) in both normal and neoplastic mammary tissue (Hilf et al, 1967;Ringler & Hilf, 1975). Furthermore, GPDH activity is higher in neoplastic tissue (Smith et al, 1966;Knox, 1967;Richards & Hilf, 1972) and neoplastic mammary tissue contains higher oestrogen-receptor concentrations than normal mammary tissue, thus suggesting a correlation between GPDH and oestrogen receptor (Daehnfeldt & Schulein, 1975). An increase in NADPH/NADP+, via raised GPDH levels, could then account for the increase in the rate of oestradiol-17, formation from oestrone in DMBA-induced tumours after oestrogen administration to oophorectomized animals.…”
Section: Discussionmentioning
confidence: 99%
“…There is well-documented evidence that oestradiol-17, induces glucose-6-phosphate dehydrogenase (GPDH) in both normal and neoplastic mammary tissue (Hilf et al, 1967;Ringler & Hilf, 1975). Furthermore, GPDH activity is higher in neoplastic tissue (Smith et al, 1966;Knox, 1967;Richards & Hilf, 1972) and neoplastic mammary tissue contains higher oestrogen-receptor concentrations than normal mammary tissue, thus suggesting a correlation between GPDH and oestrogen receptor (Daehnfeldt & Schulein, 1975). An increase in NADPH/NADP+, via raised GPDH levels, could then account for the increase in the rate of oestradiol-17, formation from oestrone in DMBA-induced tumours after oestrogen administration to oophorectomized animals.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, it has been reported that in human breast carcinomas there is a correlation between high levels of the oestrogen recep tor protein and a high G6PD activity [4], It remains to be verified whether G6PD activity and the level of the oestrogen receptor both correlate with the sex chromatin frequency in breast cancer patients. If this is so, then G6PD activity and sex chromatin frequency might supplement information gained from oestrogen receptor assays for the selection of breast cancer pa tients who might respond favourably to hormonal therapy.…”
Section: Sex Chromatin Frequency Oestrogen Receptors and Breast Cancermentioning
confidence: 95%